东方海洋: 关于全资子公司取得医疗器械注册证的公告

Group 1 - The company, Shandong Oriental Ocean Technology Co., Ltd., has received registration approval for its Interleukin-6 (IL-6) assay kit from the Shandong Provincial Drug Administration, which will enhance its product line in clinical testing [1][2] - The registered product is intended for the quantitative measurement of IL-6 levels in human serum, plasma, and whole blood, with a registration certificate valid from August 15, 2025, to August 14, 2030 [1] - The impact of the new product on the company's performance is uncertain, as it has not yet been put into production and its actual sales will depend on market expansion efforts and demand [2]